1359
CASE SUMMARY: A 66-year-old white woman with a 10-year history of hypertension and bronchial asthma was switched from immediate-release verapamil hydrocloride 40 mg tid to sustained-release verapamil 240 mg/d po for better hypertension control.
 A 66-year-old white woman with a 10-year history of hypertension and bronchial asthma: Subject; 66-year-old: Subject.Age; white: Subject.Race; woman: Subject.Gender; bronchial asthma: Subject.Disorder; switched from immediate-release verapamil hydrocloride 40 mg tid to sustained-release verapamil 240 mg/d po: Treatment; hypertension: Treatment.Disorder; hypertension: Treatment.Disorder; immediate-release verapamil hydrocloride: Treatment.Drug; sustained-release verapamil: Treatment.Drug; 240 mg/d: Treatment.Dosage; 40 mg tid: Treatment.Dosage; po: Treatment.Route
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: potential therapeutic event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Treatment.Time_elapsed, Subject.Disorder, Subject.Race, Treatment.Route, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 A 66-year-old white woman with a 10-year history of hypertension and bronchial asthma: Subject; 66-year-old: Subject.Age; white: Subject.Race; woman: Subject.Gender; bronchial asthma: Subject.Disorder; switched from immediate-release verapamil hydrocloride 40 mg tid to sustained-release verapamil 240 mg/d po: Treatment; hypertension: Treatment.Disorder; hypertension: Treatment.Disorder; immediate-release verapamil hydrocloride: Treatment.Drug; sustained-release verapamil: Treatment.Drug; 240 mg/d: Treatment.Dosage; 40 mg tid: Treatment.Dosage; po: Treatment.Route